Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

A playful game to see if it lowers anxiety in palliative care patients

Official title: SPAMLO-3.0 : Having Fun Shedding Light on Darkness

Run by Centre Hospitalier de Saint-Brieuc · NCT07070869 · Data updated 2026-11-12

A serious game called SPAMLO-3.0 is being tested to see if it helps reduce anxiety for people receiving palliative care, compared with standard care.

More Anxiety trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment280 (estimated)
SponsorCentre Hospitalier de Saint-Brieuc
Academic / other
Locations8 sites (Dinan and 7 other locations)
StatusRecruiting
StartedJuly 2027
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07070869 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in palliative care with a life expectancy >1 month, without cognitive impairments, own a device with internet access, and consent to participate.

Probably not a fit

Patients who are not anxious or who cannot engage with digital games may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests whether adding the SPAMLO-3.0 serious game to standard palliative care can reduce anxiety in patients with limited life expectancy. Participants are randomized 1:1 to either standard care alone or standard care plus playing the SPAMLO-3.0 game for up to seven days. Anxiety and secondary outcomes are measured on Day 15 and Day 30, with data collection at inclusion, Day 15, and Day 30. The trial aims to explore whether a playful, educational game can improve emotional well-being in palliative care settings.

Why it matters

Potential benefit: If successful, patients may experience lower anxiety and improved quality of life during palliative care.

How similar studies have gone: Previous work suggests that digital and educational interventions can reduce anxiety in palliative care, but results are variable and this exact game is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant for whom no curative treatment is proposed, who is either discharged home or hospitalized in palliative care
* Life expectancy presumed to be greater than one month
* No cognitive impairments, according to the healthcare team's assessment
* Participantt has given free and informed consent
* Participant affiliated with a social security system
* The participant owns a computer, tablet, or smartphone with an internet connection and agrees to participate in the serious game SPAMLO-3.0.

Exclusion Criteria:

* Participant who is demented, confused, or in a coma
* Fatigability, according to the healthcare team's assessment
* Visually or hearing impaired participant, according to the healthcare team's assessment
* No inclusion of persons targeted by Articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g., minors, legally protected adults, etc.)

Where it's running

  • Groupe Hospitalier Rance Emeraude, site René Plevin
    Dinan, France
    Recruiting
  • Centre Hospitalier de Guingamp
    Guingamp, France
    Recruiting
  • Centre Hospitalier de Lannion - Trestel
    Lannion, France
    Recruiting
  • Centre Hospitalier Centre Bretagne
    Noyal-Pontivy, France
    Recruiting
  • Centre Hopsitalier de Saint-Brieuc - Paimpol - Tréguier, site de Paimpol
    Paimpol, France
    Recruiting
  • Centre Hospitalier Universitaire de Rennes, site de la Tauvrais
    Rennes, France
    Recruiting
Show 2 more locations
  • Centre Hospitalier de Saint-Brieuc - Paimpol - Tréguier, site de Saint-Brieuc
    Saint-Brieuc, France
    Recruiting
  • HAD du Pays Briochin - Fondation AUB Santé
    Saint-Brieuc, France
    Recruiting

Study contacts

  • Principal investigator: Stéphanie LOUICHE — Centre Hospitalier de Saint-Brieuc - Paimpol - Tréguier
  • Study coordinator: Fanny BEGUIER
  • Email: fanny.beguier@armorsante.bzh
  • Phone: 0296018165

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.